Academic Pharmaceuticals, Inc.
Records under this name other than the patents Academic Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Back to Academic Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,923,447 | Parenteral solutions containing metolazone Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,427,398 | Parenteral solutions containing metolazone Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,389,451 | Metolazone Emulsion Formulation Formerly held In force · High confidence | In force | High confidence | |
| US 12,121,520 | Metolazone emulsion formulation Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,364,213 | Method of Initiating or Escalating Dofetilide Dose and Formulations Therefor Formerly held In force · High confidence | In force | High confidence | |
| US 11,957,648 | Method of Initiating or Escalating Dofetilide Dose and Formulations Therefor Formerly held In force · High confidence | In force | High confidence | |
| US 8,664,267 | Parenteral solution containing amiodarone in NNDMA (N,N,-Dimethylacetamide) Lapsed on the fee record Ended Mar 4, 2026 · From the USPTO record | Lapsed on the fee record | Ended Mar 4, 2026 | From the USPTO record |
| US 8,563,574 | Parenteral formulation of clopidogrel Lapsed on the fee record Ended Oct 22, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 22, 2025 | From the USPTO record |
| US 8,481,600 | Formulation of aspirin that is stable and showing minimal hydrolysis for parenteral administration for the treatment of cardiovascular and other disease states Lapsed on the fee record Ended Jul 9, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jul 9, 2025 | From the USPTO record |
| US 8,513,278 | Parenteral dextrose formulation of clopidogrel Lapsed on the fee record Ended Aug 20, 2021 · From the USPTO record | Lapsed on the fee record | Ended Aug 20, 2021 | From the USPTO record |